Amylyx’s Relyvrio Could See Fast Sales Growth, But Also Spark Pricing Debate

Interpret Survival Analysis “Cautiously,” Label Advises

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.